Photo: Anindito Mukherjee / Getty Images
The World Health Organization (WHO) has approved the Indian coronavirus vaccine Covaxin for emergency use. reported organization on Twitter.
“WHO has given clearance for the emergency use of Bharat Biotech’s Covaxin vaccine,” it said.
The organization noted that the drug has an efficiency of 78%, this figure is achieved 14 or more days after the second dose. It is suitable for countries “low and middle income due to simple storage requirements,” WHO said.
Gunzburg called the reasons for the long registration of “Sputnik V” in the WHO and the EU
Thus, the Indian vaccine became the seventh drug to be approved by the organization. Previously, WHO allowed the use of vaccines from Pfizer / BioNTech, Janssen (owned by Johnson & Johnson), two versions of the drug from AstraZeneca and developed by the American company Moderna, Chinese Sinopharm and Sinovac.
.